CYTOSORBENTS CORP
CYTOSORBENTS CORP
Action · US23283X2062 · CTSO · A12GDU (XNCM)
Aperçu Indicateurs financiers
1,10 USD
1,39 % 0,01 USD
NASDAQ CAPITAL MARKET (XNAS) · Cours et graphiques actuels sur MoneyPeak
13.06.2025 19:59

Cours actuels de CYTOSORBENTS CORP

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
CTSO
USD
13.06.2025 19:59
1,10 USD
1,08 USD
+1,39 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 3,31 % 31,91 % -1,35 % 6,83 % 30,17 % -87,79 %

Profil de l'entreprise pour CYTOSORBENTS CORP Action

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Données de l'entreprise

Nom CYTOSORBENTS CORP
Société Cytosorbents Corporation
Symbole CTSO
Site web https://www.cytosorbents.com
Marché d'origine XNCM NASDAQ CAPITAL MARKET
WKN A12GDU
ISIN US23283X2062
Type de titre Action
Secteur Healthcare
Industrie Medical - Devices
PDG Dr. Phillip P. Chan M.D., Ph.D.
Capitalisation boursière 64 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 305 College Road East, 08540 Princeton
Date d'introduction en bourse 2006-08-08

Fractionnements d'actions

Date Fractionnement
05.12.2014 1:25

Changements d'identifiant

Date De À
15.04.2010 MSBT CTSO

Symboles boursiers

Nom Symbole
Frankfurt HQE1.F
NASDAQ CTSO

Autres actions

Les investisseurs qui détiennent CYTOSORBENTS CORP ont également les actions suivantes dans leur portefeuille :
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Action
AMGEN INC
AMGEN INC Action
ARM HLDGS ADR NEW
ARM HLDGS ADR NEW Certificat de dépôt
AUTODESK INC
AUTODESK INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
FARMLAND PARTNERS
FARMLAND PARTNERS Action
FASTENAL CO
FASTENAL CO Action
INTEL CORP
INTEL CORP Action
LBBW GELDMARKTFONDS R
LBBW GELDMARKTFONDS R Fonds
MARRIOTT INTERNATIONAL - CLASS A
MARRIOTT INTERNATIONAL - CLASS A Action
MICROSOFT CORP
MICROSOFT CORP Action
ROB.CGF-R.BP US PR.EQ.DDL
ROB.CGF-R.BP US PR.EQ.DDL Fonds
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025